<code id='F20254117A'></code><style id='F20254117A'></style>
    • <acronym id='F20254117A'></acronym>
      <center id='F20254117A'><center id='F20254117A'><tfoot id='F20254117A'></tfoot></center><abbr id='F20254117A'><dir id='F20254117A'><tfoot id='F20254117A'></tfoot><noframes id='F20254117A'>

    • <optgroup id='F20254117A'><strike id='F20254117A'><sup id='F20254117A'></sup></strike><code id='F20254117A'></code></optgroup>
        1. <b id='F20254117A'><label id='F20254117A'><select id='F20254117A'><dt id='F20254117A'><span id='F20254117A'></span></dt></select></label></b><u id='F20254117A'></u>
          <i id='F20254117A'><strike id='F20254117A'><tt id='F20254117A'><pre id='F20254117A'></pre></tt></strike></i>

          explore

          explore

          author:leisure time    Page View:5899
          A sign of The Cigna Group in front of trees with orange and green leaves — insurance overage from STAT
          Joe Buglewicz/Bloomberg

          Cigna and Humana are in discussions to merge, a potential move that would create a health insurance and prescription drug benefits titan with approximately $300 billion of annual revenue.

          A proposed transaction would almost certainly prompt a close review from antitrust enforcers at the Department of Justice and the Federal Trade Commission. A merged Cigna-Humana would further consolidate the market for pharmacy benefit managers. PBMs are companies that serve as the controversial middlemen of drug pricing negotiations, and of the four largest, two are owned by Cigna and Humana.

          advertisement

          The Wall Street Journal first reported the talks between Cigna and Humana on Wednesday, citing sources close to the situation. Wendell Potter, a health insurance whistleblower who used to work at Cigna, also wrote about merger discussions between Cigna and Humana on his blog Tuesday.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          Insmed lung disease drug hits target in key Phase 3 trial
          Insmed lung disease drug hits target in key Phase 3 trial

          AdobeAnexperimentaldrugfromInsmedIncorporatedsuccessfullyreducedlungproblemsamongpatientswithanairwa

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Cancer diagnosis changes perspective doctor, former hospital CEO

          CourtesyRyanPickeringPROVIDENCE–InlateAugust,Dr.JamesE.FanalewastrudgingthroughtheFalmouthRoadRace—w